Histologic and molecular diagnosis of tularemia: A potential bioterriorism agent endemic to North America

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 489-495

  Lamps, Laura W ^a   Havens, Jennifer M ^a   Sjostedt, Anders ^b   Page, David L ^c   Scott, Margie A ^a,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Ctrl Arkansas Vet Hlthcare Syst ^*  (United States)

Author keywords

Bioterrorism; Francisella tularensis; Immunohistochemistry; Molecular diagnosis; Polymerase chain reaction; Tick borne; Tularemia

Indexed keywords

DNA; LIPOPROTEIN;

ABSCESS; ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AWARENESS; BIOLOGICAL WARFARE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM ULCER; ENDEMIC DISEASE; FEMALE; FRANCISELLA TULARENSIS; GENE ISOLATION; GENETIC ANALYSIS; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ABSCESS; LIVER ABSCESS; LIVER GRANULOMA; LYMPH NODE; MALE; MENINGITIS; MOLECULAR BIOLOGY; NECROTIZING PNEUMONIA; NONHUMAN; NORTH AMERICA; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SPLEEN ABSCESS; TISSUE FIXATION; TULAREMIA;

ADOLESCENT; ADULT; AGED; ANIMALS; BACTERIAL PROTEINS; BIOTERRORISM; CHILD; DNA; DNA, BACTERIAL; ENDEMIC DISEASES; FEMALE; FRANCISELLA TULARENSIS; HUMANS; INTESTINES; KIDNEY; LIPOPROTEINS; LIVER; LUNG; LYMPH NODES; MALE; MENINGES; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; NORTH AMERICA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPLEEN; TULAREMIA;

EID: 2942555740     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800087     Document Type: Article

References (38)

1. Martin GJ, Marty AM. Clinicopathologic aspects of bacterial agents. Clin Lab Med 2001;221:513-548.
2. Geyer SJ, Burkey A, Chandler FW. Tularemia. In: Connor DH, Chandler FW (eds). Pathology of Infectious Diseases. Appleton and Lange: Stamford, CT, 1997, pp 869-873.
3. Ellis J, Oyston PCF, Green M, et al. Tularemia. Clin Microbiol Rev 2002;15:631-646.
4. Anonymous. Tularemia-United States, 1990-2000. MMWR 2002;51:181-184.
5. Taylor JP, Istre GR, McChesney TC, et al. Epidemiologic characteristics of human tularemia in the southwest-central United States. Am J Epidemiol 1991;133:1032-1038.
6. Burgdorfer W, Cooney JC, Thomas LA. Zoonotic potential (Rocky Mountain spotted fever and tularemia) in the Tennessee Valley region. Am J Trop Med Hyg 1974;23:109-117.
7. Altman GB. Tularemia. A pathogen in nature and a biological weapon. AAOHN J 2002;50:373-377.
8. Sjostedt A, Eriksson U, Berglund L, et al. Detection of F. tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol 1997;35:1045-1048.
9. Guarner J, Greer PW, Bartlett J, et al. Immunohistochemical detection of Francisella tularensis in formalin-fixed, paraffin-embedded tissue. Appl Immunol Mol Morphol 1999;7:122-126.
10. Junhui Z, Ruifu Y, Jianchun L, et al. Detection of F. tularensis by the polymerase chain reaction. J Med Microbiol 1996;45:477-482.
11. Johansson A, Ibrahim A, Goransson I, et al. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of F. tularensis. J Clin Micro 2000;38:4180-4185.
12. Broussard LA. Biological agents: weapons of warfare and bioterrorism. Mol Diagn 2001;6:323-333.
13. Anonymous. Recognition of illness associated with the intentional release of a biologic agent. MMWR Wkly 2001;50:893-897.
14. Fulop M, Leslie D, Titball R. A rapid, highly sensitive method for the detection of F. tularensis in clinical samples using the polymerase chain reaction. Am J Trop Med Hyg 1996;54:364-366.
15. Sato T, Fujita H, Ohara Y, et al. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 1990;28:2372-2374.
16. Jacobs RF, Condrey YM, Yamauchi T. Tularemia in adults and children: a changing presentation. Pediatrics 1985;76:818-822.
17. Farlow J, Smith KL, Wong J, et al. F. tularensis strain typing using multiple-locus, variable number tandem repeat analysis. J Clin Microbol 2001;39:3186-3192.
18. Higgins JA, Hubalek Z, Halouzka J, et al. Detection of F. tularensis in infected mammals and vectors using a probe based PCR reaction. Am J Trop Med Hyg 2000;62:310-318.
19. De la Puente-Redondo VA, del Blanco NG, Gutierrez-Martin CB, et al. Comparison of different PCR approaches for typing of F. tularensis strains. J Clin Microbiol 2000;38:1016-1022.
20. Johansson A, Berglund L, Eriksson U, et al. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 2000;38:22-26.
21. Karhukorpi EK, Karhukorpi J. Rapid laboratory diagnosis of ulceroglandular tularemia with polymerase chain reaction. Scand J Inf Dis 2001;33:383-385.
22. Gallivan MVE, Davis II WA, Garagusi VF, et al. Fatal cat-transmitted tularemia: demonstration of the organism in tissue. South Med J 1980;73:240-242.
23. Zaidi SA, Singer C. Gastrointestinal and hepatic manifestations of tickborne diseases in the United States. Clin Inf Dis 2002;34:1206-1212.
24. Sjostedt A, Kuoppa K, Johansson T, et al. The 17kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis. Microb Pathogenesis 1992;13:243-249.
25. Berdal BP, Mehl R, Haaheim H, et al. Field detection of F. tularensis. Scand J Inf Dis 2000;32:287-291.
26. Bell JF, Stewart SJ. Chronic shedding tularemia nephritis in rodents: possible relation to occurrence of Francisella tularensis in lotic waters. J Wildlife Dis 1975;11:421-430.
27. Parker RR, Steinhaus EA, Kohls GM, et al. Contamination of natural waters and mud with Pasteurella tularensis and tularemia in beavers and muskrats in the northwestern United States. Natl Inst Health Bull 1951;193:1-61.
28. Shapiro DS, Schwartz DR. Exposure of laboratory workers to F. tularensis despite a bioterrorism procedure. J Clin Microbiol 2002;40:2278-2281.
29. Evans ME, Gregory DW, Schaffner W, et al. Tularemia: a 30 year experience with 88 cases. Medicine 1985;64:251-269.
30. Guerrant RL, Humphries Jr MK, Butler JE, et al. Tickborne oculoglandular tularemia: case report and review of seasonal and vectorial associations in 106 cases. Arch Int Med 1976;136:811-813.
31. Avery FW, Barnett TB. Pulmonary tularemia. A report of five cases and a consideration of pathogenesis and terminology. Am Rev Resp Dis 1967;95:584-591.
32. Baskerville A, Hambleton P, Dowsett AB. The pathology of untreated and antibiotic-treated experimental tularemia in monkeys. Br J Exp Pathol 1978;59:615-623.
33. Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med 1987;147:265-268.
34. Baskerville A, Hambleton P. Pathogenesis and pathology of respiratory tularemia in the rabbit. Br J Exp Pathol 1976;57:339-347.
35. Sutinen S, Syrjala H. Histopathology of human lymph node tularemia caused by F. tularensis var palaearctica. Arch Pathol Lab Med 1986;110:42-46.
36. Pittman T, Williams D, Friedman AD. A shunt infection caused by F. tularensis. Pediatr Neurosurg 1996;24:50-51.
37. Buchanan TM, Brooks GF, Brachman PS. The tularemia skin test: 325 skin tests in 210 persons: serologic correlation and review of the literature. Ann Intern Med 1971;74:336-343.
38. Robinson-Dunn B. The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med 2002;126:291-294.